RxDoctor Payments Data

Adam Gerber, DPM

Podiatrist · Caldwell, IDNPI 1780029231

Payments from drug & device makers

What this record shows

22 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 48.6% of the total. Reporting peaked in 2021 at $1,769 and has fallen 82.2% since, to $315 in 2025.

$3,302in general payments, 2019–2025

Across 63 payments — averaging $52.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$2K
  • Stryker$560
  • Bioventus LLC$196
  • Johnson & Johnson$97
  • KCI USA, Inc.$93
  • Paragon 28, Inc.$93
  • plus $659 from 16 others

What the payments were for

  • Travel & lodging$1,35741%
  • Food & beverage$1,94559%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,302 in reported general payments places this provider in the 85th percentile of 28 podiatrist providers in Idaho.

See all podiatrist providers in Idaho

Medicare billing

Part B allowed, 2024
$41,169
Medicare patients
201
Services billed
611

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin53$883
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip17$666
Cephalexin26$221
Duloxetine Hcl13$167
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen13$118

Paid to pharmacies, not to this prescriber.

Other podiatrist in Caldwell

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →